In the mouse thymus, pre-T cells are defined by their CD3~CD4~CD8~ triple-negative, CD44 
Introduction
The initial stages of thymocyte development involve a complex sequence of commitment and proliferation events. These early events result in the production of a large number of immature CD4 + CD8 + T lymphocytes from a limited number of hematopoietic precursors (1, 2) . In the adult mouse the earliest intrathymic precursor population has a CD3C D4 l0 CD8-c-/c/f + CD44 + CD25-phenotype (3, 4) . The subsequent phenotypic progression of development of these cells to the CD4 + CD8 + subset involves CD44 + CD25 + (progenitor T cells or pro-T cells), CD44~CD25 + (precursor T cells or pre-T cells) and CD44"CD25-stages (3) .
We have previously shown that TCR p gene rearrangement occurs during the transition between the pro-T to pre-T cell stages (5) . A control point of T cell development, named pselection, exists between the pre-T and CD44~CD25~ stages (1, 6, 7) . During this process the TCR p chain would be surfaceexpressed without the TCR a chain but in association with other proteins including pTa, forming a pre-TCR (8, 9) . This may be analogous to the pre-B cell receptor (10, 11) . One major consequence of pre-TCR expression would be to select those pre-T cells that have rearranged productively the TCR p gene (P-selection) (12) . Cells graduating from this screening would then undergo clonal expansion, TCR a rearrangement, and subsequent CD4 and CD8 expression (12) . Supporting this idea, in rearrangement-deficient mice like SCID or RAG-1 knock-out mice as well as in TCR p knock-out mice, but not in TCR a knock-out mice, T cell development is blocked at the pre-T cell stage (13) (14) (15) (16) These unselected pre-T cells are probably eliminated (17) . Therefore, at the pre-T cell stage, P-selection events involving expression of the pre-TCR and possibly other molecules tightly regulate the delicate balance between cell death and cell survival and subsequent differentiation Further to this, the pre-T cell stage is likely to be the major branching point between ap and 78 T cell lineages (1) . It is, however, still unknown if this divergence in TCR usage occurs at random or if it is the consequence of programmed molecular events (18) , due to the lack of relevant markers subdividing the pre-T subset. Thus, pre-T cells represent a critical step in T cell development and even through their phenotype is CD44~CD25 + , they are likely to be heterogeneous.
In order to further analyze the pre-T cell subset and the molecular events of early T cell differentiation, we searched for new surface molecules preferentially expressed at this stage. To this end we produced mAb specific for pre-T cells by immunizing rats with SCID thymocytes, which are highly enriched in pre-T cells Here we describe a mAb, IF-7, which reacts exclusively with CD44~CD25 + pre-T cells amongst all T cell subsets analyzed. Cloning of the IF-7-defined antigen revealed that it was identical to BP-3 and BST-1 antigens (19) (20) (21) . In vitro, IF-7 co-stimulates the proliferation of pre-T cells together with anti-CD3e antibody. Furthermore, addition of IF-7 to fetal thymic organ culture (FTOC) accelerated ap T cell differentiation, while yd T cell differentiation remained mostly unaffected. Moreover, IF-7 + pre-T cells poorly reconstituted the y8 lineage in FTOC These results suggest that BP-3/BST-1 may play a unique and specific role in the expansion of pre-T cells committed to the ap lineage.
Methods

Mice
Male BALB/c mice, C.B17 scid/scid mice (SCID) or pregnant BALB/c mice (4-5 weeks old) for FTOC were purchased from Simonsen Laboratories (Gilroy, CA). RAG-1 (knock-out) (14) mice were purchased from Jackson Laboratories (Bar Harbor, ME)
IF-7 mAb
We chose to produce mAb specific for pre-T cells by immunizing rats with SCID thymocytes, which are highly enriched in pre-T cells. Lewis rats (Jackson Laboratories) were immunized twice with 1X10
7 SCID thymocytes and hybridoma were obtained by fusing draining lymph node cells with the P3X myeloma cell line following conventional methods. One of the hybridomas of interest, IF-7, was subcloned and injected into athymic BALB/c mice to prepare ascites. The mAb IF-7 was purified from cell-free ascites by caprylic acid and ammonium sulfate double precipitation, and coupled to FITC following standard methods. IF-7 isotype was defined as lgG2a using a rat monoclonal typing kit (The Binding Site, Birmingham, UK) and a rat lgG2a isotype control (PharMingen, San Diego, CA) was used in all experiments.
Cytofluorometnc analysis and cell sorting
All antibodies were purchased from PharMingen unless otherwise noted. For multiparameter analysis, the following antibodies were used: anti-CD4-phycoreythnn (PE) or -biotin (clone RM4-5); anti-CD8-PE , -FITC or -biotin (clone 53-6.7); anti-CD44-PE or -biotin (clone IM7), anti-CD25-FITC or -biotin (clone 7D4); anti-TCRocp-FITC (clone H57-597); anti-TCRyS-FITC (clone GL3). Biotinylated antibodies were revealed by streptavidin-TriColor (Caltag, San Francisco, CA). Stained cells were analyzed using a FACScan calibrated with adequate controls (Becton Dickinson, San Jose, CA) and the data presented using Lysys II software (Becton Dickinson).
For FTOC reconstitution, CD44"CD25 + IF-7 + and CD44" CD25 + IF-7" thymocytes were isolated using cell sorting. Briefly, thymocytes were incubated with cytotoxic anti-CD4 (clone RL172) and anti-CD8 (clone AD4; Cedarlane, Ontario, Canada) antibodies. This was followed by treatment with low toxicity rabbit complement (Cedarlane) plus 20 ug/ml DNase I (Sigma, St Louis, MO). Viable cells were subsequently stained with a mixture of anti-CD4, anti-CD8, anti-CD3 (clone 145-2C11), anti-CD44, anti-B220 (clone RA3-6B2), anti-Mac-1 (clone M1/70), anti-Gr-1 (clone RB6-8C5), all coupled to PE, anti-CD25-biotm and IF-7-FITC, followed by streptavidinTnColor. FTOC IF-7 effects in thymic development were assessed by adding the mAb to FTOC. Briefly, six to 12 fetal thymic lobes removed at day 14 of gestation were cultured on nitrocellulose filters (Millipore, Bedford, MA) supported by gelfoam sponges soaked in FTOC medium which was identical to culture medium except that it contained 20% FCS. Different concentrations of purified IF-7 or isotype control were added at the beginning of culture and the medium was changed every 4 days.
For reconstitution experiments, fetal thymic lobes were removed at day 15 of gestation and depleted of T cell progenitors by culturing in FTOC medium containing 1.35 mM 2-deoxyguanosine as described previously (22) . Each depleted lobe was combined with 5x 10 3 sorted cells in 30 ml FTOC medium in Terasaki plate wells (Nunc, Kamstrup, Denmark). The plates were inverted to allow cells and lobes to meet at the bottom of the hanging drop (23) . After 36 h, the recolonized lobes were placed back in FTOC as described above. For all FTOC, at the end of the culture period, thymocytes were released from the lobes by gently pressing under a coverslip in 100 ml of PBS containing 2% FCS and 0.02% NaN 3 , and passed through a nylon mesh to obtain single-cell suspensions for cytofluorometric analysis.
Construction and screening of a cDNA library and DNA sequencing
mRNA was extracted from RAG-1 knock-out thymuses using RNAzol B (Tel-Test, Friendswood, TX) and then oligotex-dT mRNA kit (Quiagen, Chatsworth, CA) following manufacturer's instruction. A directional cDNA library was prepared using the Superscript Plasmid System (Gibco/BRL, Grand Island, NY) and cloned into pME18s plasmid vector. Plasmid DNA (10 |xg) was transfected into COS-7 cells by electroporation. At 48 h after transfection, cells were harvested and stained with IF-7-FITC. Positive cells were sorted using a FACStar Plus (Becton Dickinson), lysed with 10 mM EDTA and 0 6% SDS, and plasmid DNA was extracted and amplified in DH10B electrocompetent cells (Gibco/BRL). After three rounds of sorting and enrichment, individual bacterial colonies were picked randomly, plasmid DNA extract with the RPM kit (Bio 101, La Jolla, CA), and inserts sequenced using Sequenase 2.0 and Sequenase reagent kit (Amersham, Cleveland, OH) 
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Results
IF-7 reacts with pre-T cells
We examined the reactivity of IF-7 in thymic and peripheral T cells together with CD4, CD8 and CD3 expression (data not shown). We did not find any co-reactivity of IF-7 with these markers. However, IF-7 reacted with CD4~CD8~ thymocytes (data not shown). Therefore, we analyzed IF-7 reactivity in CD3"CD4"CD8" triple-negative thymocytes purified by cell sorting together with the expression of CD25 and CD44 (Fig. 1A) . We observed that IF-7 reacted only with CD44 l0/ -CD25 + triple-negative pre-T cells. These particular thymocytes are called pre-T cells in analogy with the B cell lineage, and have completed (3 and y but not a rearrangement (5) . In addition, we analyzed the same staining in RAG-1 knock-out mice and found a similar distribution (Fig. 1B) . This last observation indicates that IF-7 reactivity is independent of TCR gene rearrangement
In addition, we analyzed the co-expression of BP-3/BST-1 and CD44 in pre-T cells obtained from RAG-1 knock-out thymuses (Fig. 2) . We found that BP-3/BST-1 expression augmented as CD44 expression decreased, indicating that BP-3/BST-1" 1 " cells are probably located in the most mature portion of pre-T cells.
IF-7 recognizes BP-3/BST-1 antigen
We constructed a cDNA library from RAG-1 knock-out thymus mRNA in order to clone the antigen recognized by IF-7. We transfected the plasmid library into COS-7 cells, stained the cells with IF-7-FITC and sorted IF-7+ COS-7 cells by flow cytometry. After three rounds of enrichment, we digested DNA of 10 plasmids obtained from randomly picked colonies. Seven showed a similar insert size of 1250 bp (data not shown). The nucleic acid sequence of two of these clones was identical to BP-3 antigen cDNA (21) and also murine BST-1 antigen cDNA (19) . COS-7 cells transfected with these individual clones were IF-7 + (data not shown). We therefore conclude that IF-7 recognizes the BP-3/BST-1 antigen.
IF-7 enhances the proliferative response of pre-T cells to anti-CD3
CD44~CD25
+ pre-T cells express very low levels of CD3. While it is undetectable by immunostaining, it can be revealed by the pre-T cells' ability to respond to anti-CD3 stimulation in vitro (24) or in vivo (25) . We examined the proliferative response of sorted pre-T cells to combinations of IF-7 and anti-CD3e after cross-linking (Fig. 3) . Proliferation of pre-T cells to anti-CD3e was weak, due to the very low expression of CD3 and to the fact that a high proportion of pre-T cells die shortly after culture (A. Vicari, unpublished observations), but reproducible. IF-7 or goat anti-rat antibody alone had no effect. However, IF-7 cross-linked by goat anti-rat antibody induced a significant enhancement of the proliferative response of pre-T cells to anti-CD3e (Fig. 3) . These data Identical concentration (100 jig/ml) of purified isotype control (triangles) or IF-7 mAb (circles) was added to FTOC as described in Methods. After 11, 13 or 15 days, thymocytes were recovered from lobes, counted and analyzed for CD4, CD8 and ap TCR or y5 TCR expression by flow cytometry. Total cell number recovery per lobe for each subset is indicated in the different panels (six to 10 pooled lobes per determination). Results are expressed as mean ± SD from three independent experiments suggest that triggering BP-3/BST-1 can induce a signal in pre-T cells. However, we have not been able to find any modification of calcium flux after addition of IF-7 to sorted pre-T cells or RAG-1 knock-out thymocytes. Finally, this result also suggests that IF-7 behaves as an agonistic antibody.
IF-7 enhances and accelerates the development of fetal thymuses in organ culture
We compared the effects of purified IF-7 (100 ng/ml) and isotype control at the same concentration on the development of day 14 FTOC. Thymocytes were harvested after 11, 13 and 15 days. We analyzed the expression of CD4, CD8, ap TCR and y8 TCR by flow cytometry and calculated the total number of cells recovered per lobe for immature CD4 + CD8 + and mature CD4 + CD8"TCR hi , CD4~ CD8 + TCR hl , CD4-CD8"aP + and CD4~CD8~y8 + thymocytes (Fig. 4 ). An increased number (40%) of CD4 + CD8 + thymocytes from IF-7-treated FTOC was observed after 11 days. An increased number of mature, TCR hi , CD4+CD8-and CD4"CD8 + thymocytes in IF-7-treated FTOC was also observed, but delayed to day 13. The augmentation in the CD4"CD8"a|3 + and CD4"CD8"Y8 + subsets was far less pronounced (Fig. 4) . Finally, after 15 days, the recovery in each subset was similar in IF-7-treated FTOC or controls.
BP-3-
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Given that ROC contain a cohort of precursors which cannot be replaced by new progenitors, we conclude that IF-7 enhanced initially the recovery of the most immature CD4 + CD8 + thymocytes and later their mature progeny. Due to the absence of new precursors, this effect disappeared after 15 days. These data indicates that triggering of BP-3/ BST-1 antigen in FTOC accelerates the development of the major CD4 + CD8~ and CD4"CD8 + differentiation pathway. However, mature CD4~CD8~ thymocytes expressing ocp or y8 TCR were less affected
Repopulation of fetal thymuses with BP-3/BST-1 + or BP3/BST-1-pre-T cells
The ability of CD44 l0/ -CD25 + pre-T cells (sorted by flow cytometry based on their expression of BP-3 antigen) to reconstitute 2-deoxyguanosine-treated day 15 fetal thymus lobes was examined As BP-3/BST-1 antigen expression is low in pre-T cells, sorting gates were adjusted for the most negative and positive populations (not shown). This way, a purity >99.5% was achieved for each sort. At days 17, 20 and 23 after reconstitution, thymocytes were harvested, and analyzed for the expression of CD4, CD8, ap TCR and y8 TCR (Figs 5 and 6 ). Both BP-3/BST-1+ and BP-3/BST-r pre-T cells were able to reconstitute all CD4/CD8 defined ap + subsets. However, at each time point, thymocytes harvested from BP-3/BST-1 + reconstituted lobes were more mature than those recovered from BP-3/BST-r reconstituted lobes (Fig.  5) . The proportion of immature CD4 + CD8 + thymocytes was lower (Fig. 5 ) and the proportion of mature TCRaP hl cells in CD4 + CD8~, CD4-CD8" 1 " and CD4-CD8" thymocytes was higher (Fig. 6 ). More precisely, the proportion of CD4"CD8 + thymocytes in BP-3/BST-r reconstituted lobes was higher, but this subset was mostly constituted of TCRaP low cells, precursors of immature CD4 + CD8 + thymocytes. Interestingly, the proportion of y5 + cells among CD4~CD8~ thymocytes was much lower in the BP-3/BST-1" 1 " reconstituted fetal lobes (Fig. 6) .
The effect we observed in reconstituted lobes could be due either to the fact that BP-3/BST-1 + pre-T cells are more mature than their BP-3/BST-r counterparts (Fig. 2) , or to the effect of IF-7 antibody that we used for sorting or to a combination of both. Therefore, we analyzed the ability of sorted total pre-T cells to reconstitute day 15 2-deoxyguanosine-treated fetal thymus lobes independently of their BP-3/ BST-1 expression, but either stained or not with IF-7 (Fig. 7) . We observed a greater proportion of mature TCRap hl cells in thymocytes recovered from lobes reconstituted with IF-7-stained pre-T cells (data shown for CD4~CD8 + thymocytes). Again, the percentage of y8 + cells was much lower in CD4C D8" thymocytes recovered from these lobes (data not shown).
These results strongly suggest that the effects observed in reconstituted fetal lobes reflect the physiological in vivo situation. Pre-T cells that express BP-3/BST-1 would be ready to undergo a rapid differentiation process through physiological BP-3/BST-1 triggering in vivo or under artificial conditions like IF-7 staining and therefore would appear more mature 
Discussion
Pre-T cells represent a crucial transition stage in early T cell development Therefore, study of the expression and function of surface molecules specifically expressed at this time would certainly increase our understanding of this process. We describe here a mAb, IF-7, that, among all T cell subsets analyzed, reacts only with CD44 l0/~C D25 + pre-T cells. Expression cloning of the antigen recognized by IF-7 showed complete identity to the published sequence of BP-3 and mouse BST-1 antigen cDNAs (19, 21) . Thus, by using IF-7, we analyzed the distribution and possible functions of BP-3/BST-1 antigen during intrathymic early T cell development.
The murine BP-3 antigen is a variably glycosylated glycosylphosphatidylinositol-linked molecule that is selectively expressed by early B cells and a discrete subpopulation of reticular cells in peripheral lymphoid organs (26, 27) . It is also expressed on the brush border of intestinal epithelial cells, the luminal surface of renal collecting tubules and mature myeloid cells (27) . Although it has been reported in immature T lymphocytes, its expression and function during T cell differentiation is poorly documented (21, 26, 27) . Human BST-1 antigen has been isolated from bone marrow stromal cell lines (20) , and the coding cDNA sequence of BP-3 and murine BST-1 are identical (19, 21) . Is noteworthy that BP-3/ BST-1 activation facilitates pre-B cell growth (20, 21) . We report here that triggering BP-3/BST-1 antigen in vitro in pre-T cells or in FTOC accelerates and enhances ap T cell differentiation. Thus, the role of BP-3/BST-1 could be to promote pre-T as well as pre-B cell growth.
Interestingly, we were able to detect BP3/BST1 expression on mouse thymic stromal cells (data not shown). Such expression has not been reported before and may be due to differences in epitope recognition by different anti-BP-3 antibodies (20, 21) . Interestingly, fibroblasts transfected with BP-3/ BST-1 gene can stimulate the growth of a pre-B cell line (20) , suggesting homotypic interactions. Similarly, we found that BP-3/BST-1 was expressed both in pre-T cells and thymic stromal cells. Thus, homotypic interactions through BP-3/BST-1 may occur in the thymus as well as in the bone marrow. In IF-7-treated fetal thymic lobes, the effects we observed could have been the result of the interaction of IF-7 with pre-T cells and/or stromal cells. However, the fact that we observed a strong and similar effect of IF-7 in reconstitution experiments where pre-T cells have been exposed to IF-7 only during cell sorting indicates that activation of pre-T cells through IF-7 was largely contributing to the effects of IF-7 on T cell development.
In the adult mouse thymus, pre-T cells define the first stage when TCR p and y gene rearrangements are completed (5,12) However, it has been shown that most p gene rearrangements at this stage are out-of-frame. Conversely, the next step in T cell differentiation, defined by a CD44" CD25" phenotype, showed a majority of in-frame p gene rearrangements (12) . Several groups have concluded that a selection process for productive TCR p rearrangements, named p-selection, is crucial during this transition (1, 7, 28) . P-selection is thought to be mediated by a pre-TCR, resulting from the association of the p chain with-pTa (7-9). A major phenomenon following p-selection is strong clonal expansion (12) : the proportion of cycling cells in the CD44"CD25" subset is much higher than in the CD44"CD25 + subset (29, 30) , and the former is undergoing rapid expansion in cell number (29, 31) . However, although expression of a pre-TCR is certainly a major component of the engagement of pre-T cells in further differentiation, there is some evidence that other unknown factors could interfere in this process. Indeed, it has been shown that CD4~CD8~ thymocytes from RAG-2 knockout mice could differentiate into CD4 + CD8 + cells after irradiation and without TCR gene rearrangement (17) . Interestingly, under the same conditions it was possible to detect B cell differentiation in the bone marrow (17) . We also injected IF-7 into RAG-1 knock-out mice but did not observe CD4 or CD8 expression (data not shown). However, we found that pre-T cells recovered from IF-7-injected mice expressed high levels of CD24, which is normally up-regulated during the transition from the pre-T cell to the CD44~CD25~stage (data not shown) (3) . We therefore propose that BP-3/BST-1 triggering could play a important role in both pre-T and pre-B cell development, independently of antigen receptor gene rearrangement.
We also found that the development of CD4"CD8"y5 + thymocytes was poorly affected by BP-3/BST-1 triggering and that BP-3/BST-1 + pre-T cells reconstituted poorly the y6
lineage. This finding suggests that BP-3/BST-1 would play only a role in the mainstream ap differentiation pathway of T cells, where the most important expansion is found. In addition, this would indicate that the ap/y8 lineage decision is mainly made at the pre-T cell stage. Our data are reminiscent of the observations recently made in mice deficient for pTa: the inactivation of the pTa gene blocks the ap pathway but not the yd pathway (34) . Together with pTa expression, BP-3/BST-1 expression may be a marker of pre-T cells committed to the ap lineage. Our observations of a slight increase in y8 T cells after IF-7 treatment (Fig. 4) and that some y8 T cells were produced in fetal thymic lobes reconstituted with BP-3 + pre-T cells (Fig. 6) suggest that some BP-3 + pre-T cells are precursors of y5 T cells. This may be due to the fact that a few 78 T cells can diverge later than p-selection and the pre-T cell stage, as it has been shown previously (12) . Further analyses, like the relative expressions of BP-3/BST-1 and pTa in pre-T cells may help resolve this issue.
The molecular basis of BP-3/BST-1 function is still unknown. Sequence analysis showed some homology between BP-3/ BST-1 and CD38, a NAD glycohydrolase involved in B cell proliferation (32, 33 ). An analogous enzymatic activity for BP-3/BST-1 has been found in one report (20) , but not in another (21) . Finally, it has been described that BST-1 expression is enhanced in bone marrow stromal cell lines derived from patients with rheumatoid arthritis (20) It would therefore be of interest to analyze the immunopathological consequences of dysregulation of BP-3/BST-1 antigen expression.
